New Alzheimer’s drug may slow cognitive decline
For the first time, researchers have described the structure of a special type of amyloid beta plaque protein. associated with the progression of Alzheimer's disease (EA). In a study, published in the magazine 'Neurona'scientists have shown that small aggregates of the amyloid beta protein could float through brain tissue fluidreach many regions of the brain and alter the functioning of local neurons. The research also provides evidence that a recently approved AD treatment could neutralize these small diffusible aggregates. Alzheimer's, one of the causes of dementia, affects more than 50 million people worldwide. Previous research has found that AD patients…
